Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 11;19(2):172-176.
doi: 10.22074/ijfs.2024.2028815.1687.

Efficacy of Hyoscine N-butyl Bromide on Cervical Dilatation Prior to Hysteroscopy Procedure: An Open-Label Randomized Controlled Trial

Maryam Sadat Hosseini  1 , Farah Farzaneh  1 , Hanieh Najafiarab  1 , Saba Bazzazi  2
Affiliations

Efficacy of Hyoscine N-butyl Bromide on Cervical Dilatation Prior to Hysteroscopy Procedure: An Open-Label Randomized Controlled Trial

Maryam Sadat Hosseini et al. Int J Fertil Steril. .

Abstract

Background: Due to the high prevalence of intrauterine pathologies, postmenopausal women are more eligible for hysteroscopy procedure. Cervical dilatation is always a major challenge for performing hysteroscopy. The present study aimed to determine the efficacy of vaginal Hyoscine N-butylbromide (HBB) on cervical dilatation prior to hysteroscopy in postmenopausal women.

Materials and methods: This open-label randomized controlled trial was conducted on postmenopausal women who were scheduled for hysteroscopy. Eligible patients were randomly assigned with a ratio of 1:1 to the intervention (received 20 mg HBB vaginally two hours prior to hysteroscopy) and control (did not receive HBB) groups. As the study outcomes, pre-hysteroscopy cervical dilatation (based on the passage of the dilator number 4 through the cervical canal) and the adverse event consequences were compared between the two groups.

Results: Overall, 128 postmenopausal women who were eligible for hysteroscopy were included in the study, with 64 individuals in each group. The percentage of cervical dilatation in the intervention group was significantly higher than the control group (100 vs. 70.3%, P<0.001). Furthermore, none of the adverse event consequences differed significantly between the intervention and control groups: bleeding (3.1 vs. 3.1%, P>0.999), nausea and vomiting (4.7 vs. 0%, P=0.244), dry mouth (3.1 vs. 0%, P=0.496), dizziness (0 vs. 0%), and headache (0 vs. 0%).

Conclusion: Based on the findings, vaginal HBB is effective without any significant side effects in cervical dilation of postmenopausal women (registration number: IRCT20220822055772N1).

Keywords: Cervical dilatation; Hysteroscopy; Postmenopause; Scopolamine.

PubMed Disclaimer

Figures

Fig 1
Fig 1
CONSORT flow diagram of the study.
Fig 2
Fig 2
Percentage of cervical dilatation in the intervention and control groups.
Fig 3
Fig 3
Adverse event consequences followed by hysteroscopy.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Romanski PA, Bortoletto P, Pfeifer SM. A framework approach for hysteroscopic uterine septum incision: partial and complete. Fertil Steril. 2022;118(1):205–206. - PubMed
    1. Mirgaloybayat S, Madadian M, Tahermanesh K, Derakhshan R, Sarhadi S, Rokhgireh S. Comparative study of the effects of sublingual trinitroglycerin and sublingual misoprostol on cervical preparation before hysteroscopy: a randomized controlled trial. Clin Exp Obstet Gynecol. 2024;51(7):167–167.
    1. Hota T, Abuzeid O, Raju R, Holmes J, Hebert J, Abuzeid M. Management of false passage complication during operative hysteroscopy. Middle East Fertil Soc J. 2022;27(1):11–11.
    1. Vitale SG, De Angelis MC, Della Corte L, Saponara S, Carugno J, Laganà AS, et al. Uterine cervical stenosis: from classification to advances in management.Overcoming the obstacles to access the uterine cavity. Arch Gynecol Obstet. 2024;309(3):755–764. - PMC - PubMed
    1. Samy A, Nabil H, Abdelhakim AM, Mahy ME, Abdel-Latif AA, Metwally AA. Pain management during diagnostic office hysteroscopy in postmenopausal women: a randomized study. Climacteric. 2020;23(4):397–403. - PubMed

LinkOut - more resources